Robot trainer aims to get stroke patients back on their feet

NCT ID NCT07034521

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study tests a new robot system (HIWIN MRG-P110) designed to help chronic stroke survivors improve their walking. The robot uses foot pedals to guide leg movements and can adjust how much it helps versus how much the patient must do on their own. Researchers will enroll 60 people who had a stroke 6 months to 3 years ago and compare two training modes: one where the robot does most of the work and one where it encourages active effort. The goal is to see which approach leads to better walking speed, balance, and brain activity changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REHABILITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taipei, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HIWIN MRG-P110 robot system for gait training

What this could lead to

If successful, this could provide a new, more effective rehabilitation option for chronic stroke survivors to improve their walking ability.

What could go wrong

This is an early feasibility study with only 60 participants, so results may not apply to all stroke survivors. The robot is new and its benefits over standard therapy are unproven.

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.